377 related articles for article (PubMed ID: 18751909)
21. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
23. The endocannabinoid system in ageing: a new target for drug development.
Paradisi A; Oddi S; Maccarrone M
Curr Drug Targets; 2006 Nov; 7(11):1539-52. PubMed ID: 17100593
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of the endocannabinoid system in obesity.
Engeli S
J Neuroendocrinol; 2008 May; 20 Suppl 1():110-5. PubMed ID: 18426509
[TBL] [Abstract][Full Text] [Related]
25. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition.
Rossi S; De Chiara V; Musella A; Sacchetti L; Cantarella C; Castelli M; Cavasinni F; Motta C; Studer V; Bernardi G; Cravatt BF; Maccarrone M; Usiello A; Centonze D
Mol Pharmacol; 2010 Aug; 78(2):260-8. PubMed ID: 20424126
[TBL] [Abstract][Full Text] [Related]
26. Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction.
Battista N; Pasquariello N; Di Tommaso M; Maccarrone M
J Neuroendocrinol; 2008 May; 20 Suppl 1():82-9. PubMed ID: 18426505
[TBL] [Abstract][Full Text] [Related]
27. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
28. Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids.
Steffens M; Schulze-Bonhage A; Surges R; Feuerstein TJ
Neurosci Lett; 2005 Sep; 385(1):13-7. PubMed ID: 15923084
[TBL] [Abstract][Full Text] [Related]
29. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
[TBL] [Abstract][Full Text] [Related]
30. Phylogenomic and chemotaxonomic analysis of the endocannabinoid system.
McPartland JM
Brain Res Brain Res Rev; 2004 Apr; 45(1):18-29. PubMed ID: 15063097
[TBL] [Abstract][Full Text] [Related]
31. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels.
de Lago E; Petrosino S; Valenti M; Morera E; Ortega-Gutierrez S; Fernandez-Ruiz J; Di Marzo V
Biochem Pharmacol; 2005 Aug; 70(3):446-52. PubMed ID: 15963472
[TBL] [Abstract][Full Text] [Related]
32. Focus on the three key enzymes hydrolysing endocannabinoids as new drug targets.
Vandevoorde S; Lambert DM
Curr Pharm Des; 2005; 11(20):2647-68. PubMed ID: 16101463
[TBL] [Abstract][Full Text] [Related]
33. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.
Cravatt BF; Demarest K; Patricelli MP; Bracey MH; Giang DK; Martin BR; Lichtman AH
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9371-6. PubMed ID: 11470906
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
Fichna J; Sałaga M; Stuart J; Saur D; Sobczak M; Zatorski H; Timmermans JP; Bradshaw HB; Ahn K; Storr MA
Neurogastroenterol Motil; 2014 Apr; 26(4):470-81. PubMed ID: 24460851
[TBL] [Abstract][Full Text] [Related]
35. Nuclear localisation of the endocannabinoid metabolizing enzyme fatty acid amide hydrolase (FAAH) in invasive trophoblasts and an association with recurrent miscarriage.
Chamley LW; Bhalla A; Stone PR; Liddell H; O'Carroll S; Kearn C; Glass M
Placenta; 2008 Nov; 29(11):970-5. PubMed ID: 18805581
[TBL] [Abstract][Full Text] [Related]
36. Role of FAAH-like anandamide transporter in anandamide inactivation.
Leung K; Elmes MW; Glaser ST; Deutsch DG; Kaczocha M
PLoS One; 2013; 8(11):e79355. PubMed ID: 24223930
[TBL] [Abstract][Full Text] [Related]
37. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
Labar G; Vliet FV; Wouters J; Lambert DM
Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
[TBL] [Abstract][Full Text] [Related]
38. Vanilloid receptor 1 (TRPV1/VR1) co-localizes with fatty acid amide hydrolase (FAAH) in retinal amacrine cells.
Zimov S; Yazulla S
Vis Neurosci; 2007; 24(4):581-91. PubMed ID: 17686199
[TBL] [Abstract][Full Text] [Related]
39. Latest advances in the discovery of fatty acid amide hydrolase inhibitors.
Bisogno T; Maccarrone M
Expert Opin Drug Discov; 2013 May; 8(5):509-22. PubMed ID: 23488865
[TBL] [Abstract][Full Text] [Related]
40. A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase.
Kage KL; Richardson PL; Traphagen L; Severin J; Pereda-Lopez A; Lubben T; Davis-Taber R; Vos MH; Bartley D; Walter K; Harlan J; Solomon L; Warrior U; Holzman TF; Faltynek C; Surowy CS; Scott VE
J Neurosci Methods; 2007 Mar; 161(1):47-54. PubMed ID: 17083980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
